PRESS-RELEASE ·Filed Jul 22, 2026
Press release: earnings
Actionable Insight • Neutral
This is a routine earnings date announcement with no financial content. Traders should await the Q2 2026 earnings release on August 5, 2026, for revenue, EPS, and pipeline updates that may move the stock.
Latest settled — T+20d
CHRS ▼ -6.99% at T+20d
NEUTRAL call ✗ call lost -6.99% · α vs SPY -9.89% · entry $1.43 → $1.33
Latest observation: T+49 +17.85% FF3 residual α
T+1d
0.00%
call 0.00% · α +1.23%
$1.43
settled 2mo ago
T+5d
-1.40%
call -1.40% · α +1.00%
$1.41
settled 2mo ago
T+20d
-6.99%
call -6.99% · α -9.89%
$1.33
settled 6w ago
T+60d
—
call — · α —
—
in 13d
Price Chart
Loading chart...
Executive Summary
Coherus Oncology announced the release date for its Q2 2026 financial results (August 5, 2026) and scheduled a conference call. No financial results or guidance were provided in this filing.
Key Facts
- Q2 2026 financial results to be released on August 5, 2026.
- Conference call and webcast scheduled for 5:00 p.m. EDT on August 5, 2026.
- Press release and materials will be available on the investor relations website before the call.
Financial Impact
No financial data in this filing; material information will be released on August 5, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331650 |
11 reports for CHRS
67% Hit rate best @ T+5▲ +16.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Press Release | $1.34 $1.29 | ▼ −4.10% | ▼ −3.11% | $1.17 (−12.69%) |
Jul 22, 2026 10w ago | Press Release | $1.43 $1.33 | ▼ −6.99% | ▼ −9.89% | $1.17 (−18.18%) |
Jun 15, 2026 15w ago | 8-K | $1.38 $1.45 | ▲ +5.07% | ▲ +4.87% | $1.17 (−15.22%) |
Jun 12, 2026 16w ago | Institutional Cluster | $1.40 $1.54 | ▼ −10.00% | ▼ −8.22% | $1.17 (+16.43%) |
May 28, 2026 18w ago | DEFA14A | $1.65 $1.50 | ▼ −9.09% | ▼ −5.95% | $1.17 (−29.09%) |
May 11, 2026 20w ago | Press Release | $1.71 $1.36 | ▼ −20.47% | ▼ −18.74% | $1.17 (−31.58%) |
May 5, 2026 21w ago | DEFA14A | $1.75 $1.47 | ▼ −16.00% | ▼ −18.78% | $1.17 (−33.14%) |
May 4, 2026 21w ago | Press Release | $1.73 $1.57 | ▼ −9.25% | ▼ −14.89% | $1.17 (−32.37%) |
Mar 9, 2026 29w ago | Press Release | $1.95 $1.70 | ▼ −12.82% | ▼ −12.67% | $1.17 (−40.00%) |
Mar 2, 2026 30w ago | Press Release | $1.65 $1.60 | ▼ −3.03% | ▲ +4.91% | $1.17 (−29.09%) |
Showing 10 of 11
US Market Status
Market Open — Closes in 28m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access